Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report

• Ningning Yan,
• Ziheng Zhang,
• Sanxing Guo,
• Shujing Shen,
• Xingya Li

Affiliations

Ningning Yan

Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Ziheng Zhang

Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Sanxing Guo

Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Shujing Shen

Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Xingya Li

Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China